experspadmin

Central Dopamine Blockade in the Pathophysiology of Tardive Dyskinesia
Psychiatry

Central Dopamine Blockade in the Pathophysiology of Tardive Dyskinesia

expert roundtables
By Leslie Citrome, MD, MPH; Andrew J. Cutler, MD; Rakesh Jain, MD, MPH
Practice Guidelines on Tardive Dyskinesia
Psychiatry

Practice Guidelines on Tardive Dyskinesia

expert roundtables
By Leslie Citrome, MD, MPH; Andrew J. Cutler, MD; Rakesh Jain, MD, MPH
Dopamine Receptor–Blocking Agent Exposure in the Pathophysiology of Tardive Dyskinesia
Psychiatry

Dopamine Receptor–Blocking Agent Exposure in the Pathophysiology of Tardive Dyskinesia

clinical topic updates
By Andrew J. Cutler, MD
Antipsychotic Switching Strategies in Tardive Dyskinesia
Psychiatry

Antipsychotic Switching Strategies in Tardive Dyskinesia

clinical topic updates
By Andrew J. Cutler, MD
Clinical Trials, Long-term Follow-up, and Experience With VMAT2 Inhibitors
Psychiatry

Clinical Trials, Long-term Follow-up, and Experience With VMAT2 Inhibitors

clinical topic updates
By Andrew J. Cutler, MD
Load More